All posts by: admin

About admin

by Thomas LynchVice President, Client Services, AldevronBoard Member, BioForward The team at Aldevron is excited to virtually celebrate our recent expansion in Madison and share the great progress we’re making and opportunities ahead in the world of gene therapy. Aldevron’s Protein Business Unit manufactures recombinant proteins used in a wide range of applications including research, […]

By Mike HarrisonBioForward Manager, Business Development This has been a tough year for everyone, but as someone with young children, my thoughts are often with the many families experiencing hardships this holiday season.  With increasing job loss, food insecurity, and constant uncertainty at school, the low-income families in Milwaukee have been suffering beyond what most […]

By Brian MoellerBioForward Director, Operations & Member Services This past year was challenging for all of us in a whole host of ways, though as the crisis continued to drag on it became clear that not enough was done to protect those who are most at-risk in our communities and that more help might not […]

By Lisa JohnsonBioForward CEO I am inspired every day when I see how so many people give their creativity, time, and money to support our communities and those in need. I know I could do much more and have had to self-reflect on being too self-centered and does that bring me as much joy as […]

In June 2018, University of Wisconsin-Madison student and Wisconsin native, Cate Wilkinson, joined the team at BioForward Wisconsin as our Communications, Marketing, and Events Intern.  She was going to school to earn her Bachelor of Science in Microbiology. She thought that joining BioForward, as a biohealth membership association, would afford her the opportunity to learn […]

Read the full press release from Catalent here. Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has signed an agreement with Spicona, Inc. to develop a virus-like protein (VLP)-based vaccine against COVID-19. Under the terms […]

Read the full press release from Illumina here. Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. […]

Read the full story from WISBUSINESS here. Virologists at the Morgridge Institute for Research are investigating the biology of viruses and their diseases in order to develop powerful new methods to not only control COVID-19 but stem the next pandemic. According to the institute, COVID-19 illustrates how viral threats are growing more common, underscoring the […]